P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845912.50259.67 |
| _version_ | 1827336370484412416 |
|---|---|
| author | A. Bazinet E. Jabbour H. Kantarjian K. Chien C. DiNardo M. Ohanian N. Daver R. Kanagal-Shamanna T. Kadia K. Takahashi L. Masarova N. Short Y. Alvarado P. Thompson G. Montalban-Bravo M. Yilmaz F. Ravandi M. Konopleva M. Andreeff S. Kornblau N. Pemmaraju D. Hammond H. Schneider B. Mirabella G. Garcia-Manero |
| author_facet | A. Bazinet E. Jabbour H. Kantarjian K. Chien C. DiNardo M. Ohanian N. Daver R. Kanagal-Shamanna T. Kadia K. Takahashi L. Masarova N. Short Y. Alvarado P. Thompson G. Montalban-Bravo M. Yilmaz F. Ravandi M. Konopleva M. Andreeff S. Kornblau N. Pemmaraju D. Hammond H. Schneider B. Mirabella G. Garcia-Manero |
| author_sort | A. Bazinet |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:30:34Z |
| format | Article |
| id | doaj.art-f473c73c044b4d5ba7072abefa4863a6 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:30:34Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-f473c73c044b4d5ba7072abefa4863a62024-03-02T06:40:50ZengWileyHemaSphere2572-92412022-06-01665265310.1097/01.HS9.0000845912.50259.67202206003-00652P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIAA. Bazinet0E. Jabbour1H. Kantarjian2K. Chien3C. DiNardo4M. Ohanian5N. Daver6R. Kanagal-Shamanna7T. Kadia8K. Takahashi9L. Masarova10N. Short11Y. Alvarado12P. Thompson13G. Montalban-Bravo14M. Yilmaz15F. Ravandi16M. Konopleva17M. Andreeff18S. Kornblau19N. Pemmaraju20D. Hammond21H. Schneider22B. Mirabella23G. Garcia-Manero241 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia2 Hematopathology, University of Texas MD Anderson Cancer Center, Houston, United States of America1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemiahttp://journals.lww.com/10.1097/01.HS9.0000845912.50259.67 |
| spellingShingle | A. Bazinet E. Jabbour H. Kantarjian K. Chien C. DiNardo M. Ohanian N. Daver R. Kanagal-Shamanna T. Kadia K. Takahashi L. Masarova N. Short Y. Alvarado P. Thompson G. Montalban-Bravo M. Yilmaz F. Ravandi M. Konopleva M. Andreeff S. Kornblau N. Pemmaraju D. Hammond H. Schneider B. Mirabella G. Garcia-Manero P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA HemaSphere |
| title | P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| title_full | P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| title_fullStr | P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| title_full_unstemmed | P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| title_short | P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| title_sort | p757 results of a phase 1 study of azacitidine combined with venetoclax for treatment naive and relapsed high risk myelodysplastic syndrome and chronic myelomonocytic leukemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000845912.50259.67 |
| work_keys_str_mv | AT abazinet p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT ejabbour p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT hkantarjian p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT kchien p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT cdinardo p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT mohanian p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT ndaver p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT rkanagalshamanna p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT tkadia p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT ktakahashi p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT lmasarova p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT nshort p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT yalvarado p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT pthompson p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT gmontalbanbravo p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT myilmaz p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT fravandi p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT mkonopleva p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT mandreeff p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT skornblau p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT npemmaraju p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT dhammond p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT hschneider p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT bmirabella p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia AT ggarciamanero p757resultsofaphase1studyofazacitidinecombinedwithvenetoclaxfortreatmentnaiveandrelapsedhighriskmyelodysplasticsyndromeandchronicmyelomonocyticleukemia |